Skip links

Headquartered in Bratislava, Slovak Republic, MABPRO, a.s. is building an immunotherapy platform for aggressive hypoxic tumors using carbonic anhydrase IX (CAIX) as a therapeutic target. Copyright © 2025 All rights reserved to the comapny MABPRO, a.s.